WeVote
Log In

Bill

Bill

S 4190

Requires DHS to submit Medicaid State plan amendment to federal government requesting approval to create Health Home Program for certain Medicaid beneficiaries with sickle cell disease.

2026-2027 Regular Session Introduced by Angela McKnight

New Jersey would seek federal approval to create a Medicaid Health Home Program for sickle cell disease patients to boost coordinated, integrated care.

0
WeVote Research Nonpartisan
Bill Summary · S 4190

Bill Summary: S 4190 (New Jersey, Session 222)

Title

Requires DHS to submit Medicaid State plan amendment to federal government requesting approval to create Health Home Program for certain Medicaid beneficiaries with sickle cell disease.

Purpose and Intent

  • The bill directs the New Jersey Department of Human Services (DHS) to pursue a Medicaid State Plan Amendment (SPA) to establish a Health Home Program specifically for Medicaid beneficiaries who have sickle cell disease (SCD).
  • The overarching goal is to improve care coordination, care management, and overall health outcomes for individuals with SCD who are enrolled in Medicaid.

Key Provisions

  • Mandate to Submit SPA: DHS must prepare and submit a Medicaid State Plan Amendment to the federal government seeking approval to establish a Health Home Program tailored to beneficiaries with sickle cell disease.
  • Target Population: The program would apply to Medicaid recipients diagnosed with sickle cell disease.
  • Program Focus: Health homes are usually designed to provide comprehensive, patient-centered care coordination, including primary, specialty, behavioral health, and social services integrated through care managers and multidisciplinary teams.
  • Funding/Structure (Implied): While specifics are not detailed in the summary, approval of an SPA typically enables federal Medicaid matching funds (FMAP) for the health home services, subject to federal approval and state plan terms. The bill would authorize the state to implement the program through DHS upon federal authorization.
  • Implementation Plan: The bill requires the state to develop the SPA and submit it to federal authorities, with DHS overseeing program design, provider enrollment, care coordination protocols, and performance measurement.

Who Would Be Affected

  • Medicaid Beneficiaries with SCD: Primary recipients who would receive coordinated, comprehensive care under the health home model, potentially including enhanced care management, care coordination, and access to a broader set of health and social services.
  • Healthcare Providers and Care Teams: Primary care providers, hematologists, specialists, behavioral health professionals, and care managers who would participate in the health home model and coordinate services for eligible beneficiaries.
  • State Agency Administration: New Jersey DHS would oversee development, submission of the SPA, program implementation, reimbursement, and ongoing management of the health home initiative.

Procedural and Timeline Considerations

  • Administrative Process: The key procedural step is the preparation and submission of a Medicaid State Plan Amendment to the federal Centers for Medicare & Medicaid Services (CMS) seeking approval for the Health Home Program for SCD patients.
  • Federal Review and Approval: The timeline will depend on federal approval timelines and any stipulations or conditions set by CMS for Medicaid SPA approval.
  • Implementation Post-Approval: Upon federal approval, the state would implement the health home program, including establishing care coordination protocols, enrolling eligible beneficiaries, contracting with providers, and setting up performance metrics and reporting.
  • Funding Considerations: Deployment would align with federal FMAP funding for health homes, subject to SPA terms and state budget processes.

Potential Impacts

  • Clinical Impact: Improved care coordination and access to integrated services may reduce acute complications, ER visits, and hospitalizations among SCD patients.
  • Economic Impact: Potentially better long-term cost efficiency for Medicaid through reduced inpatient and emergency care, balanced against the administrative costs of program setup and ongoing management.
  • Equity and Access: Focused program could address gaps in care for individuals with sickle cell disease, which disproportionately affect certain populations.

If you’d like, I can add hypothetical timelines, compare with existing health home programs, or translate this into plain-language guidance for affected patients and providers.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.